HHS is exploring approaches to controlling specialty drug pricing in Medicare Part D through a process of binding arbitration, according to HHS Assistant Secretary for Planning and Evaluation Richard Frank.
HHS Envisions Drug Price Arbitration For Part D
Approaches for HHS to become involved in drug price negotiations between Medicare Part D plan sponsors and manufacturers were outlined by HHS Assistant Secretary for Planning and Evaluation Richard Frank at a policy conference, although current law would need to be revised to allow it.